In the News

Share

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

460 News Items found
Dr. Bob Li
First Drug Targeting HER2-Mutant Non-Small Cell Lung Cancer Approved by FDA

The FDA has approved the drug trastuzumab deruxtecan for the treatment of advanced non-small cell lung cancer driven by mutant HER2. An MSK-led study published in September 2021 contributed to the drug's approval.
Dr. Craig Thompson in his lab at the Sloan Kettering Institute
New MSK Research Reveals How Mitochondria Function Under Stress Like Cancer

Mitochondria provide both the energy cells need to survive and the building blocks they need to grow and divide. Researchers at the Sloan Kettering Institute reveal for the first time how mitochondria choose between these opposing paths — and what implications it may have for cancer.
Samuel Danishefsky
Memorial Sloan Kettering Enters Agreement to Develop New Cancer Drug

As part of a commitment to seek new and better treatments for cancer patients, Memorial Sloan Kettering Cancer Center and Bristol-Myers Squibb are collaborating to bring a potential new cancer drug called iso-fludelone, or KOS-1803, into clinical trials.
Ingo Mellinghoff, Chair of the Department of Neurology at Memorial Sloan Kettering
Brain Trust: 8 Questions with Ingo Mellinghoff

Ingo Mellinghoff is optimistic about the future of brain cancer treatments as the new Chair of MSK’s Department of Neurology.
MSK researcher in a lab
MSK Research Highlights, August 24, 2023

New MSK research suggests a method for revealing DNA repair “scars” could help make treatment decisions in BRCA1- and BRCA2-deficient cancers; modified a bacteria-made compound to target mutant KRAS-driven cancers; and shed new light on brain metastasis in non-small cell lung cancer.
MSK scientists Andrew Kung and Elli Papaemmanuil
New Type of Genetic Testing Aims To Benefit Children and Young Adults With Cancer

By sequencing the entire genome of a tumor, the experimental test will go beyond standard testing for common cancers in adults.
SKI immunologist Justin Perry holding a fish
Meet Justin Perry, a “Card-Carrying Alaskan” Whose Love for Science Took Him on an Unexpected Journey

Read an interview with Sloan Kettering Institute immunologist Justin Perry.
In the Lab
Microscopic image of cancer cells and C. elegans cells undergoing entosis.
A Death Wish That Allows Worms to Thrive — and What It Tells Us About Cancer Biology

Researchers discover that a curious type of cell death plays a role in normal development.
Woman waving a pom pom at the Cycle for Survival event at MetLife Stadium
Celebrating 15 Years of Cycle for Survival and Announcing Upcoming Events at MSK

Every day, your commitment to funding life-changing cancer research at Memorial Sloan Kettering is ensuring a brighter future for people with cancer around the world. Thank you for your continued support.
Event
Pictured: 2014 Graduates
Memorial Sloan Kettering Celebrates at Convocation and Commencement Ceremony

Degrees were presented and awards were given at the 35th annual ceremony held on May 14.